KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Inventory: 2017-2024

Historic Inventory for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to $612.5 million.

  • Amneal Pharmaceuticals' Inventory rose 3.04% to $614.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $614.5 million, marking a year-over-year increase of 3.04%. This contributed to the annual value of $612.5 million for FY2024, which is 5.34% up from last year.
  • Amneal Pharmaceuticals' Inventory amounted to $612.5 million in FY2024, which was up 5.34% from $581.4 million recorded in FY2023.
  • Amneal Pharmaceuticals' Inventory's 5-year high stood at $612.5 million during FY2024, with a 5-year trough of $489.4 million in FY2021.
  • For the 3-year period, Amneal Pharmaceuticals' Inventory averaged around $574.9 million, with its median value being $581.4 million (2023).
  • Per our database at Business Quant, Amneal Pharmaceuticals' Inventory climbed by 28.76% in 2020 and then dropped by 0.26% in 2021.
  • Amneal Pharmaceuticals' Inventory (Yearly) stood at $490.6 million in 2020, then declined by 0.26% to $489.4 million in 2021, then rose by 8.45% to $530.7 million in 2022, then rose by 9.54% to $581.4 million in 2023, then grew by 5.34% to $612.5 million in 2024.